The use of cannabis to treat the symptoms of cancer and associated treatments is well known, but a growing body of evidence shows how cannabis can also be used as a direct anticancer agent. In this presentation, preclinical studies showing the anticancer effects of specific cannabinoids will be discussed, along with human reports of remissions from aggressive cancers after using high doses of cannabinoids.
1. Describe the basic biological mechanisms by which cannabinoids have been shown to inhibit cancers
2. Understand the human and clinical evidence demonstrating how preclinical effects are translating to humans